We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Engineered Non-Viral Gene Vectors for Combination Cancer Therapy: A Review.
Journal of Biomedical Nanotechnology 2017 December 2
Following the US Food and Drug Administration's approval of gene therapy drugs, the great potential of disease gene therapy is once again being taken seriously. However, finding a safe and efficient gene delivery vector remains the biggest challenge to successful gene therapy. To overcome this, engineered non-viral gene delivery vectors are continually being developed, despite their lower efficiencies compared with viral vectors. However, the complex biological barriers and instability caused by charge interactions mean that, no major breakthroughs have been made in the clinical development of these non-viral gene vectors. Nevertheless, the functions of the engineered polymer gene carriers are continuously expanding, and success has been achieved with the combined use of therapeutic molecules and targeted delivery. These polymer gene-carrier vectors offer a broader choice of new treatments for diseases ever before.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app